Getting your Trinity Audio player ready...

Access to reduced-price medication is vital for many low-income rural Tennesseans and the clinics serving them are concerned about potential cuts to a program that helps with drug costs.

The 340B program allows safety-net providers, like community health centers, to purchase outpatient medications at discounted rates.

Emily Waitt Hise, policy and advocacy manager for the Tennessee Primary Care Association, said the savings are crucial.

“The 340B program allows health center patients to receive the care they need to attain their highest level of health,” Waitt Hise asserted. “It ensures that all patients can receive the lifesaving medications they need to manage chronic conditions, like diabetes or high cholesterol.”

She pointed out health centers are required to reinvest the savings from the program back into patient care, which helps them provide other services like pediatrics, behavioral and dental health and OB/GYN care. Health centers are concerned that the 340B program will be on the chopping block under the new administration.

Laura Harris, CEO of Chota Community Health Services, said the 340B program offers significant cost savings, which are passed on to low-income and uninsured patients. She noted the costs vary by drug but are generally minimal. Her organization did a recent patient survey, confirming the cost savings.

“This third patient said, ‘Eliquis was going to cost me $500, because my insurance denied it. With the program, it only cost $50,'” Harris reported. “A fourth patient said, ‘My inhaler was over $100, but I got it for $25.'”

Harris argued the biggest challenge with the program is the pharmaceutical manufacturers’ contract pharmacy restrictions, which limit 340B pricing to one pharmacy. She added it forces patients on multiple medications to visit different pharmacies to fill their prescriptions, which is challenging in rural areas.